Alva Review-Courier -

By Carla K. Johnson
AP Medical Writer 

Doping drug gives no edge to serious cyclists in study

 


The blood booster at the heart of the Lance Armstrong doping scandal does not improve real-world cycling performance, according to the most rigorous study yet of how the protein EPO affects athletes.

The results, published Thursday in the journal Lancet Haematology , may convince some to pay more attention to the harms of supposed performance-enhancing drugs by punching holes in the myths surrounding them, researchers said.

Dutch scientists staged a bike race up a mountain to study whether erythropoietin (EPO) lives up to its reputation, transporting a large group of avid cyclists to southe...



For access to this article please sign in or subscribe.



 

Reader Comments
(0)

 
 

Our Family of Publications Includes:

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2020